Vertex Pharmaceuticals Incorporated (VRTX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD),…
Source: Yahoo Finance
Sector & Industry
Vertex Pharmaceuticals Incorporated operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Vertex Pharmaceuticals Incorporated at a Glance
| Company | Vertex Pharmaceuticals Incorporated |
| Ticker | VRTX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $546.12 |
| Market cap | $138.42B |
| P/E ratio (trailing) | 31.84 |
| EPS (trailing) | $17.15 |
| 52-week high | $560.25 |
| 52-week low | $374.17 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.32 |
| Return on equity (ROE) | 23.54% |
| Debt-to-equity | 9.77% |
| Average volume | 1.48M |
| Shares outstanding | 253.46M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 6,400 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Vertex Pharmaceuticals Incorporated's current P/E ratio?
- Vertex Pharmaceuticals Incorporated (VRTX) has a trailing P/E ratio of 31.84 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Vertex Pharmaceuticals Incorporated's market capitalisation?
- Vertex Pharmaceuticals Incorporated's market cap is $138.42B based on our latest snapshot. See how it ranks by market cap →
- What is VRTX's 52-week range?
- Over the past 52 weeks, VRTX has traded between $374.17 and $560.25. What does the 52-week range mean? →
- How volatile is Vertex Pharmaceuticals Incorporated compared to the market?
- Vertex Pharmaceuticals Incorporated has a beta of 0.32, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Vertex Pharmaceuticals Incorporated pay a dividend?
- Vertex Pharmaceuticals Incorporated does not currently pay a dividend according to our latest data.
- What exchange is VRTX listed on?
- VRTX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Vertex Pharmaceuticals Incorporated in?
- Vertex Pharmaceuticals Incorporated is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →